Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100

Experimental Hematology

Volumn 37, Issue 3, 2009, Pages

  Bonig, Halvard ^a,b   Chudziak, Doreen ^b   Priestley, Greg ^a   Papayannopoulou, Thalia ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; BETA1 INTEGRIN; BROXURIDINE; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; DIPEPTIDYL PEPTIDASE IV; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; L SELECTIN; PLERIXAFOR; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CYCLE G0 PHASE; CELL LABELING; CONTINUOUS INFUSION; CONTROLLED STUDY; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL MOBILIZATION;

MUS;

EID: 59749093239     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.10.017     Document Type: Article

References (59)

1. Schmitz N., Linch D.C., Dreger P., et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347 (1996) 353-357
2. Switzer G.E., Goycoolea J.M., Dew M.A., Graeff E.C., and Hegland J. Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently?. Bone Marrow Transplant 27 (2001) 917-923
3. Semerad C.L., Christopher M.J., Liu F., et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106 (2005) 3020-3027
4. Kim H.K., De La Luz Sierra M., Williams C.K., Gulino A.V., and Tosato G. G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood 108 (2006) 812-820
5. Carlo-Stella C., Cesana C., Regazzi E., et al. Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor. Exp Hematol 28 (2000) 216-224
6. Moncada V., Bolan C., Yau Y.Y., and Leitman S.F. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim. Transfusion 43 (2003) 495-501
7. Mijovic A., Pagliuca A., and Mufti G.J. The "G-CSF test": the response to a single dose of granulocyte colony-stimulating factor predicts mobilization of hemopoietic progenitors in patients with hematologic malignancies. Exp Hematol 27 (1999) 1204-1207
8. Burt R.K., Fassas A., Snowden J., et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 28 (2001) 1-12
9. Openshaw H., Stuve O., Antel J.P., et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 54 (2000) 2147-2150
10. Blaise D., Kuentz M., Fortanier C., et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Socitete Francaise de Greffe de Moelle. J Clin Oncol 18 (2000) 537-546
11. Liles W.C., Broxmeyer H.E., Rodger E., et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102 (2003) 2728-2730
12. Devine S.M., Flomenberg N., Vesole D.H., et al. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol 22 (2004) 1095-1102
13. Devine S.M., Vij R., Rettig M., et al. Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Blood 112 (2008) 990-998
14. Liles W.C., Rodger E., Broxmeyer H.E., et al. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion 45 (2005) 295-300
15. Flomenberg N., Devine S.M., DiPersio J.F., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106 (2005) 1867-1874
16. Hoglund M., Smedmyr B., Bengtsson M., et al. Mobilization of CD34+ cells by glycosylated and nonglycosylated G-CSF in healthy volunteers-a comparative study. Eur J Haematol 59 (1997) 177-183
17. Liu F., Wu H.Y., Wesselschmidt R., Kornaga T., and Link D.C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5 (1996) 491-501
18. Bonig H., Priestley G.V., Oehler V., and Papayannopoulou T. Hematopoietic progenitor cells (hpc) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC. Exp Hematol 35 (2007) 326-334
19. Bonig H., Priestley G.V., and Papayannopoulou T. Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines. Blood 107 (2006) 79-86
20. Bonig H., Priestley G.V., Oehler V., and Papayannopoulou T. Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC. Exp Hematol 35 (2007) 326-334
21. Szilvassy S.J., Humphries M.J., Lansdorp P.M., Eaves A.C., and Eaves C.J. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci U S A 87 (1990) 8736-8740
22. Darzynkiewicz Z. Simultaneous analysis of cellular RNA and DNA content. Methods Cell Biol 41 (1994) 401-420
23. Katayama Y., Hidalgo A., Furie B.C., Vestweber D., Furie B., and Frenette P.S. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood 102 (2003) 2060-2067
24. Broxmeyer H.E., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201 (2005) 1307-1318
25. Drize N., Chertkov J., Samoilina N., and Zander A. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice. Exp Hematol 24 (1996) 816-822
26. Levesque J., Hendy J., Winkler I., Takamatsu Y., and Simmons P. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol 31 (2003) 109-117
27. Gold J., Valinski H.M., Hanks A.N., Ballen K.K., Hsieh C.C., and Becker P.S. Adhesion receptor expression by CD34+ cells from peripheral blood or bone marrow grafts: correlation with time to engraftment. Exp Hematol 34 (2006) 680-687
28. Levesque J.P., Takamatsu Y., Nilsson S.K., Haylock D.N., and Simmons P.J. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98 (2001) 1289-1297
29. Larochelle A., Krouse A., Metzger M., et al. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood 107 (2006) 3772-3778
30. Kawada H., and Ogawa M. Hematopoietic progenitors and stem cells in murine muscle. Blood Cells Mol Dis 27 (2001) 605-609
31. Issarachai S., Priestley G.V., Nakamoto B., and Papayannopoulou T. Cells with hemopoietic potential residing in muscle are itinerant bone marrow-derived cells. Exp Hematol 30 (2002) 366-373
32. Williams C.D., Linch D.C., Watts M.J., and Thomas N.S. Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation. Blood 90 (1997) 194-203
33. Scott M.A., Apperley J.F., Bloxham D.M., et al. Biological properties of peripheral blood progenitor cells mobilized by cyclophosphamide and granulocyte colongy-stimulating factor. Br J Haematol 97 (1997) 474-480
34. Wright D.E., Cheshier S.H., Wagers A.J., Randall T.D., Christensen J.L., and Weissman I.L. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood 97 (2001) 2278-2285
35. van Pel M., Van Os R., Velders G.A., et al. Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization. Proc Natl Acad Sci U S A 103 (2006) 1469-1474
36. Chen J., Larochelle A., Fricker S., Bridger G., Dunbar C.E., and Abkowitz J.L. Mobilization as a preparative regimen for hematopoietic stem cell transplantation. Blood 107 (2006) 3764-3771
37. Papayannopoulou T., Priestley G.V., Bonig H., and Nakamoto B. The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization. Blood 101 (2003) 4739-4747
38. Liu F., Poursine-Laurent J., and Link D.C. Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF. Blood 95 (2000) 3025-3031
39. Liu F., Poursine-Laurent J., and Link D.C. The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand. Blood 90 (1997) 2522-2528
40. Nie Y., Han Y.C., and Zou Y.R. CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med 205 (2008) 777-783
41. Kyriakou C., Rabin N., Pizzey A., Nathwani A., and Yong K. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 93 (2008) 1457-1465
42. Adler B.K., Salzman D.E., Carabasi M.H., Vaughan W.P., Reddy V.V., and Prchal J.T. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood 97 (2001) 3313-3314
43. Grigg A.P. Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia. Blood 97 (2001) 3998-3999
44. Schrezenmeier H., Passweg J.R., Marsh J.C.W., et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia: a report from the European Group for Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant Research. Blood 110 (2007) 1397-1400
45. Smith A.L., Jungnam J., Rao S., et al. Significant alterations in T-cell TH1 and TH2 cytokine gene profiles associated with G-CSF mobilization do not occur in T-cells mobilized with AMD3100. Blood 110 (2007) 3277a
46. Gorin N.C., Labopin M., and Rocha V. Higher incidence of relapse with peripheral blood over marrow as source of stem cells in adult patients with acute myelocytic leukemia autografted in first remission. A retrospective study from the acute leukemia working party of the European group for blood and marrow transplantation. Exp Hematol 36 (2008) S2
47. Avecilla S.T., Hattori K., Heissig B., et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10 (2004) 64-71
48. Pulliam A.C., Hobson M.J., Ciccone S.L., et al. AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice. Exp Hematol 36 (2008) 1084-1090
49. Donahue R.E., Kirby M.R., Metzger M.E., Agricola B.A., Sellers S.E., and Cullis H.M. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87 (1996) 1644-1653
50. Kiel M.J., Yilmaz O.H., Iwashita T., Terhorst C., and Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005) 1109-1121
51. Shen H., Cheng T., Olszak I., et al. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J Immunol 166 (2001) 5027-5033
52. Moore M.A., Hattori K., Heissig B., et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci 938 (2001) 36-45 discussion 45-37
53. Pelus L.M., Bian H.M., Fukuda S., Wong D., Merzouk A., and Salari H. CTCE0021, a peptide agonist of stromal cell-derived factor-1 alpha (SDF-1), rapidly mobilizes polymorphonuclear neutrophils (PMN) and hematopoietic stem and progenitor cells following single administration and synergizes with G-CSF for both effects. Blood 100 (2002) 608a
54. Foudi A., Jarrier P., Zhang Y., et al. Reduced retention of radioprotective hematopoietic cells within the bone marrow microenvironment in CXCR4-/- chimeric mice. Blood 107 (2006) 2243-2251
55. Ma Q., Jones D., Borghesani P.R., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 95 (1998) 9448-9453
56. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., and Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 111 (2003) 187-196
57. Carion A., Benboubker L., Herault O., et al. Stromal-derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony-stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells. Br J Haematol 122 (2003) 918-926
58. Christopherson II K.W., Uralil S.E., Porecha N.K., Zabriskie R.C., Kidd S.M., and Ramin S.M. G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells. Exp Hematol 34 (2006) 1060-1068
59. Christopher M.J., Hilton M.J., Long F., and Link D.C. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood 110 (2007) 220a